The announcement follows a funding agreement between CEPI and global pharmaceutical company MSD to support continued development of a Zaire ebolavirus vaccine. Under the agreement, CEPI will provide ...
Add Yahoo as a preferred source to see more of our stories on Google. Samsung Biologics will conduct a simulated outbreak response using wild-type H5 influenza as a prototype pathogen The Coalition ...
The Coalition for Epidemic Preparedness Innovations (CEPI) and CDMO Samsung Biologics formed a partnership to strengthen vaccine manufacturing preparedness for future epidemic and pandemic threats.
OSLO, Norway and INCHEON, South Korea, Feb. 3, 2026 /PRNewswire/ -- The Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics (KRX: 207940.KS), a leading contract development ...
Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure Partnership strengthens global preparedness against a significant pandemic ...
SK-IDT-Vaxxas consortium establishes strategic entry point for high-density microarray patch (HD-MAP) vaccines in Europe to ...
If licensed and in the event of an influenza pandemic, Moderna will allocate 20% of its H5 pandemic vaccine manufacturing capacity for timely supply to low- and middle-income countries at affordable ...
Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure If licensed and in the event of an influenza pandemic, Moderna will allocate 20% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results